ATE475426T1 - Behandlung oder prävention von hämorrhagischen virusinfektionen mit immunomodulatorischen verbindungen - Google Patents

Behandlung oder prävention von hämorrhagischen virusinfektionen mit immunomodulatorischen verbindungen

Info

Publication number
ATE475426T1
ATE475426T1 AT05813862T AT05813862T ATE475426T1 AT E475426 T1 ATE475426 T1 AT E475426T1 AT 05813862 T AT05813862 T AT 05813862T AT 05813862 T AT05813862 T AT 05813862T AT E475426 T1 ATE475426 T1 AT E475426T1
Authority
AT
Austria
Prior art keywords
prevention
treatment
virus infections
immunomodulatory compounds
hemorrhagic virus
Prior art date
Application number
AT05813862T
Other languages
English (en)
Inventor
Eric Mossel
Cynthia Tuthill
Alfred Rudolph
Clarence Peters
Original Assignee
Sciclone Pharmaceuticals Inc
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sciclone Pharmaceuticals Inc, Univ Texas filed Critical Sciclone Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE475426T1 publication Critical patent/ATE475426T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05813862T 2004-10-27 2005-10-27 Behandlung oder prävention von hämorrhagischen virusinfektionen mit immunomodulatorischen verbindungen ATE475426T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62202204P 2004-10-27 2004-10-27
PCT/US2005/038834 WO2006047702A2 (en) 2004-10-27 2005-10-27 Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds

Publications (1)

Publication Number Publication Date
ATE475426T1 true ATE475426T1 (de) 2010-08-15

Family

ID=36228480

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05813862T ATE475426T1 (de) 2004-10-27 2005-10-27 Behandlung oder prävention von hämorrhagischen virusinfektionen mit immunomodulatorischen verbindungen

Country Status (19)

Country Link
US (1) US8193152B2 (de)
EP (1) EP1814566B1 (de)
JP (1) JP4874985B2 (de)
KR (1) KR20070070202A (de)
CN (1) CN101048171B (de)
AT (1) ATE475426T1 (de)
AU (1) AU2005299609A1 (de)
BR (1) BRPI0517401A (de)
CA (1) CA2585457A1 (de)
DE (1) DE602005022612D1 (de)
EA (1) EA012342B1 (de)
ES (1) ES2350087T3 (de)
IL (1) IL182710A (de)
MX (1) MX2007005092A (de)
NO (1) NO20072498L (de)
NZ (1) NZ555322A (de)
SG (1) SG163601A1 (de)
UA (1) UA92727C2 (de)
WO (1) WO2006047702A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006116053A1 (en) * 2005-04-22 2006-11-02 Sciclone Pharmaceuticals, Inc. Immunomodulator compounds as vaccine enhancers
MX2009008641A (es) * 2007-02-13 2009-09-14 Sciclone Pharmaceuticals Inc Composiciones para el tratamiento o prevencion del deterioro, lesion o daño a tejido debido a enfermedad de las mucosas.
EP2675272A4 (de) * 2011-02-09 2015-03-11 Sciclone Pharmaceuticals Inc Thymosin-alpha-peptid zur prävention, linderung und behandlung von infektionen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744452A (en) * 1995-11-28 1998-04-28 Edward T. Wei γ-L-glutamyl containing immunomodulator compounds and methods therewith
US5916878A (en) * 1995-11-28 1999-06-29 Edward T. Wei γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
SG169362A1 (en) 2004-05-14 2011-03-30 Sciclone Pharmaceuticals Inc Treatment or prevention of respiratory viral infections with immunomodulator compounds
UA12948U (en) 2005-07-11 2006-03-15 Inst Of Veterinary Medicine Uk Associated inactivated concentrated serdosan vaccine against colibacteriosis, edematous disease, pasteurellosis, salmonellosis, and anaerobic enterotoxicemia of pigs

Also Published As

Publication number Publication date
DE602005022612D1 (de) 2010-09-09
IL182710A (en) 2012-04-30
NZ555322A (en) 2009-02-28
WO2006047702A2 (en) 2006-05-04
KR20070070202A (ko) 2007-07-03
JP4874985B2 (ja) 2012-02-15
MX2007005092A (es) 2007-07-04
EA012342B1 (ru) 2009-10-30
BRPI0517401A (pt) 2008-10-14
SG163601A1 (en) 2010-08-30
WO2006047702A3 (en) 2006-07-20
US20090143313A1 (en) 2009-06-04
AU2005299609A1 (en) 2006-05-04
CN101048171A (zh) 2007-10-03
EP1814566B1 (de) 2010-07-28
JP2008518031A (ja) 2008-05-29
EP1814566A4 (de) 2008-05-07
NO20072498L (no) 2007-05-15
US8193152B2 (en) 2012-06-05
CA2585457A1 (en) 2006-05-04
IL182710A0 (en) 2007-07-24
UA92727C2 (ru) 2010-12-10
ES2350087T3 (es) 2011-01-18
CN101048171B (zh) 2011-02-09
EA200700878A1 (ru) 2007-10-26
EP1814566A2 (de) 2007-08-08

Similar Documents

Publication Publication Date Title
LT4445900T (lt) Terapiniai junginiai, skirti živ viruso infekcijai gydyti
TW200733953A (en) Materials and methods for treating viral infections
ATE512976T1 (de) Hemmer des hepatitis-c-virus
ATE526341T1 (de) Makrozyklische verbindungen als antivirale mittel
CY1113038T1 (el) Τριετεροκυκλικες ενωσεις, συνθεσεις, και μεθοδοι για τη θεραπεια καρκινου
DE602005019700D1 (de) E, die sich für die behandlung von hepatitis-c-virusinfektionen eignen
RU2013119607A (ru) Полициклические гетероциклические соединения и способы их применения для лечения вирусных заболеваний
CL2004001161A1 (es) Compuestos describe compuestos derivados de quinolina; composicion farmaceutica; y su uso para tratar una enfermedad causada por el virus de la hepatitis c.
IS7533A (is) Lifrarbólgu C-veirutálmar
RU2015114543A (ru) Способы лечения гепатита с
NO20045247L (no) Nukleosidderivater for behandling av hepatitt C-virusinfeksjon
NO20061788L (no) HIV-replikasjonshemmede purinderivater
EA201290882A1 (ru) Конденсированные трициклические силильные соединения и способы их применения для лечения вирусных заболеваний
EA200900156A1 (ru) Пиридазиновое соединение (варианты), способ его получения (варианты), способ лечения или профилактики инфекционного вирусного гепатита с с его помощью, композиция и лекарственное средство на его основе
EA200701869A1 (ru) Пептидомиметические ингибиторы протеазы
BR0316771A (pt) Compostos para o tratamento ou a prevenção de infecções por flavivirus, uso de um composto e composição farmacêutica
NO20073632L (no) Behandling av hepatitt C med interferon-beta i en asiatisk populasjon
EA201591328A1 (ru) Замещенные гетероциклом тетрациклические соединения и способы их применения для лечения вирусных заболеваний
EA201170484A1 (ru) Терапевтический режим лечения гепатита, включающий пэг-интерферон, рибавирин и vx-950
TW200508218A (en) Inhibitors of papilloma virus
EA201071230A1 (ru) Лечение инфекций вирусом гепатита с телапревиром (vx-950) у пациентов, не отвечающих на лечение пегилированным интерфероном-альфа-2а/2в и рибавирином
EA201001748A1 (ru) Соединения, используемые для лечения гепатита с
EA200700718A1 (ru) Комбинированные противовирусные композиции, содержащие кастаноспермин, и способы их применения
ATE475426T1 (de) Behandlung oder prävention von hämorrhagischen virusinfektionen mit immunomodulatorischen verbindungen
ATE421882T1 (de) Schnellösliches azithromycin in einzeldosisform

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties